Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication-Reference-Cited by-同舟云学术

Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication

Published:2022-07 Issue:3 Volume:149 Page:81-84
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:Journal of Pharmacological Sciences

Author:

Tsuji Genichiro^ORCID,Nakajima Shogo,Watashi Koichi,Torii Shiho,Suzuki Rigel,Fukuhara Takasuke,Ohoka Nobumichi,Inoue Takao,Demizu Yosuke

Funder

AMED

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine

Reference6 articles.

1. Deposition and metabolism of inhaled ciclesonide in the human lung;Nave;Eur Respir J,2010

2. Molecular pharmacology of ciclesonide against SARS-CoV-2;Matsuyama;J Allergy Clin Immunol,2020

3. The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells;Matsuyama;J Virol,2021

4. Development of ciclesonide analogues that block SARS-CoV-2 RNA replication;Tsuji;Bioorg Med Chem Lett,2021

5. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment;Ohashi;iScience,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Execution of a Scalable Route to an Immunology ADC Drug-Linker for ABBV-154;Organic Process Research & Development;2024-06-25

2. Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication;Viruses;2023-02-06

3. Coronavirus disease 2019 and severe asthma;Current Opinion in Allergy & Clinical Immunology;2023-01-20